Table 1.

The characteristics of the study population

	Prostate cancer	BPHa	P value
Age (Years)b	71.00 ± 11.00	67.00 ± 13.00	0.12
PSA(ng/ml)b	15.54 ± 39.21	8.70 ± 5.78	<0.01
PCA3 score	111.37 ± 278.26	17.76 ± 72.71	<0.01
<35	22 (19.6)	15 (62.5)	<0.01
≥35	90 (80.4)	9 (37.5)
% free PSAb	0.12 ± 0.08	0.18 ± 0.17	0.03
Biopsy Gleason score
≤7	75 (67.0)
≥8	37 (33.0)

^aBPH, benign prostatic hyperplasia

^bMedian ± interquartile range